Published in Drug Law Weekly, June 27th, 2006
Cost-containment efforts, including the increased substitution of generics for brand drugs, could actually cause a decline in the market, as critical care units do their part to curb overall hospital expenditures. Indeed, factors affecting the markets for pharmaceuticals in the critical care setting are complex, as elements of both cost containment and the ability to most effectively treat ICU...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.